IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers 
WCDPQ Plans South American Expansion in 2027, Including 30 New Positions Hepion Pharmaceuticals to Participate in ACS-JPS Webinar on AI Drug Development
EDISON, N.J., March 16, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Hepion Pharmaceuticals to Participate in ACS-JPS Webinar on AI Drug Development
EDISON, N.J., March 16, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance
Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps…
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance
Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps…
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Management to host investor conference call and webcast at 4:30pm ET on that day PHOENIX,…
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Management to host investor conference call and webcast at 4:30pm ET on that day PHOENIX,…
Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
CHATHAM, N.J., March 16, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
CHATHAM, N.J., March 16, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533…
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533…
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET SAN JOSE,…
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET SAN JOSE,…
Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
Company to host conference call March 16, 2023, at 4:30 PM EDT SEATTLE, Wash. and…
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
Company to host conference call March 16, 2023, at 4:30 PM EDT SEATTLE, Wash. and…
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
The Newly Issued Patent is Expected to Provide Protection into 2040 Pipeline Focus on Pan-Caspase…
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
The Newly Issued Patent is Expected to Provide Protection into 2040 Pipeline Focus on Pan-Caspase…
CymaBay Reports Fourth Quarter and Year Ended December 31, 2022 Financial Results and Provides Corporate Update
Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., March 16, 2023 (GLOBE…
CymaBay Reports Fourth Quarter and Year Ended December 31, 2022 Financial Results and Provides Corporate Update
Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., March 16, 2023 (GLOBE…